申请人:Alam Muzaffar
公开号:US20110071150A1
公开(公告)日:2011-03-24
Compounds of the formula I:
or pharmaceutically acceptable salts thereof,
wherein R
1
, R
2
, R
3
and R
4
are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with calcium release-activated calcium channels (CRAC).
公式I的化合物:
或其药用可接受的盐,
其中R1、R2、R3和R4按本文定义。还公开了制造这些化合物的方法以及使用这些化合物治疗与钙释放激活钙通道(CRAC)相关疾病的用途。